标题
Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity
作者
关键词
-
出版物
CYTOKINE & GROWTH FACTOR REVIEWS
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-06-30
DOI
10.1016/j.cytogfr.2022.06.003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Low-Dose IL-2 Treatment Affords Protection against Subarachnoid Hemorrhage Injury by Expanding Peripheral Regulatory T Cells
- (2021) Guoping Dong et al. ACS Chemical Neuroscience
- IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
- (2021) Yuying Liu et al. NATURE IMMUNOLOGY
- An engineered IL-2 partial agonist promotes CD8+ T cell stemness
- (2021) Fei Mo et al. NATURE
- The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes
- (2021) Shen Dong et al. JCI Insight
- Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus
- (2021) Pengcheng Zhou et al. PLoS Pathogens
- Low dose IL-2 for treating moderate to severe alopecia areata. A 52 weeks multicenter prospective placebo-controlled study assessing its impact on T regulatory cells and natural killer populations
- (2020) Florence Le Duff et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interleukin-2 signals converge in a lymphoid–dendritic cell pathway that promotes anticancer immunity
- (2020) Miro E. Raeber et al. Science Translational Medicine
- Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis
- (2020) Laura Elisa Buitrago-Molina et al. JOURNAL OF AUTOIMMUNITY
- Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
- (2019) Jing He et al. ANNALS OF THE RHEUMATIC DISEASES
- Germinal center TFH cells: T(w)o be or not t(w)o be, IL-6 is the answer
- (2019) Pengcheng Zhou et al. Science Immunology
- Inhibition of IL-2 responsiveness by IL-6 is required for the generation of GC-TFH cells
- (2019) Amber Papillion et al. Science Immunology
- Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren’s syndrome
- (2018) Miao Miao et al. ANNALS OF THE RHEUMATIC DISEASES
- Low Dose Interleukin-2 for Refractory Autoimmune Hepatitis
- (2018) Tiong Y. Lim et al. HEPATOLOGY
- IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren’s Syndrome Patients
- (2018) Jing Luo et al. Frontiers in Immunology
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
- (2018) Michelle Rosenzwajg et al. ANNALS OF THE RHEUMATIC DISEASES
- Regulatory T cells in the treatment of disease
- (2018) Amir Sharabi et al. NATURE REVIEWS DRUG DISCOVERY
- IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression
- (2017) Nicolas Hipp et al. Nature Communications
- IL-21 restricts T follicular regulatory T cell proliferation through Bcl-6 mediated inhibition of responsiveness to IL-2
- (2017) Christoph Jandl et al. Nature Communications
- Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation
- (2017) Jacqueline-Yvonne Cephus et al. Cell Reports
- Interleukin-2-Dependent Allergen-Specific Tissue-Resident Memory Cells Drive Asthma
- (2016) Brian D. Hondowicz et al. IMMUNITY
- EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells
- (2016) Jianhua Li et al. NATURE
- Metabolic maintenance of cell asymmetry following division in activated T lymphocytes
- (2016) Katherine C. Verbist et al. NATURE
- An essential role for the IL-2 receptor in Treg cell function
- (2016) Takatoshi Chinen et al. NATURE IMMUNOLOGY
- IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity
- (2016) Yoichiro Ohne et al. NATURE IMMUNOLOGY
- Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
- (2016) Jing He et al. NATURE MEDICINE
- Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study
- (2016) Laurence Fardet et al. PLOS MEDICINE
- Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
- (2015) Caroline von Spee-Mayer et al. ANNALS OF THE RHEUMATIC DISEASES
- Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
- (2015) Jens Y Humrich et al. ANNALS OF THE RHEUMATIC DISEASES
- Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes
- (2015) Aixin Yu et al. DIABETES
- The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells
- (2015) John P. Ray et al. IMMUNITY
- Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
- (2015) Michelle Rosenzwajg et al. JOURNAL OF AUTOIMMUNITY
- Bcl-6 directly represses the gene program of the glycolysis pathway
- (2014) Kenneth J Oestreich et al. NATURE IMMUNOLOGY
- High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
- (2014) Janice P Dutcher et al. Journal for ImmunoTherapy of Cancer
- IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts
- (2013) L. J. Berglund et al. BLOOD
- PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
- (2013) Erin E. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation
- (2012) André Ballesteros-Tato et al. IMMUNITY
- The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study
- (2011) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages
- (2011) Wei Liao et al. NATURE IMMUNOLOGY
- Foxp3+ follicular regulatory T cells control the germinal center response
- (2011) Michelle A Linterman et al. NATURE MEDICINE
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-2 Costimulation Enables Statin-Mediated Activation of Human NK Cells, Preferentially through a Mechanism Involving CD56+ Dendritic Cells
- (2010) G. Gruenbacher et al. CANCER RESEARCH
- Prolonged Interleukin-2Rα Expression on Virus-Specific CD8+ T Cells Favors Terminal-Effector Differentiation In Vivo
- (2010) Vandana Kalia et al. IMMUNITY
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
- (2010) Yenkel Grinberg-Bleyer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Infections as triggers and complications of systemic lupus erythematosus
- (2008) A Doria et al. AUTOIMMUNITY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started